These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 1375657)

  • 1. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
    Vokes EE; Haraf DJ; McEvilly JM; Mick R; Kozloff MF; Goldman MD; Moran WJ; Clendeninn NJ; Collier MA; Weichselbaum RR
    Ann Oncol; 1992 Jan; 3(1):79-81. PubMed ID: 1606074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease.
    Vokes EE; Kies M; Haraf DJ; Mick R; Moran WJ; Kozloff M; Mittal B; Pelzer H; Wenig B; Panje W
    J Clin Oncol; 1995 Apr; 13(4):876-83. PubMed ID: 7707114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
    Oh JL; Vokes EE; Kies MS; Mittal BB; Witt ME; Weichselbaum RR; Haraf DJ
    Ann Oncol; 2003 Apr; 14(4):564-9. PubMed ID: 12649102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
    Mantz CA; Vokes EE; Stenson K; Kies MS; Mittal B; Witt ME; List MA; Weichselbaum RR; Haraf DJ
    Cancer J; 2001; 7(2):140-8. PubMed ID: 11324767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation.
    Mantovani G; Macciò A; Massa E; Mulas C; Mudu MC; Massidda S; Massa D; Murgia V; Ferreli L; Succu G; Astara G; Proto E; Tore G; Mura M; Maxia G
    Oncol Rep; 1999; 6(6):1425-30. PubMed ID: 10523724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
    Clark JR; Busse PM; Norris CM; Andersen JW; Dreyfuss AI; Rossi RM; Poulin MD; Colevas AD; Tishler RB; Costello R; Lucarini JW; Lucarini D; Thornhill L; Lackey M; Peters E; Posner MR
    J Clin Oncol; 1997 Sep; 15(9):3100-10. PubMed ID: 9294473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four days' continuous infusion of cisplatin-5-fluorouracil and short daily infusion of high-dose leucovorin as induction chemotherapy for locally advanced head and neck cancer.
    Cruz JJ; Fonseca E; Muñoz A; Nieto A; Gomez A; Garcia J; Martin G; Sanchez P; Panadero A; Garcia MJ
    J Infus Chemother; 1995; 5(3):125-8. PubMed ID: 8528969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation.
    Mantovani G; Maccio A; Massa E; Mulas C; Mudu MC; Massidda S; Massa D; Murgia V; Ferreli L; Succu G; Astara G; Proto E; Tore G; Mura M; Maxia G
    Int J Oncol; 2000 Jun; 16(6):1227-33. PubMed ID: 10812000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
    Mantovani G; Proto E; Massa E; Mulas C; Madeddu C; Mura L; Mudu MC; Astara G; Murgia V; Gramignano G; Ferreli L; Camboni P; Lusso MR; Mocci M; Tore G; Mura M; Amichetti M; Maccio A
    Int J Oncol; 2002 Feb; 20(2):419-27. PubMed ID: 11788911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
    Kies MS; Haraf DJ; Athanasiadis I; Kozloff M; Mittal B; Pelzer H; Rademaker AW; Wenig B; Weichselbaum RR; Vokes EE
    J Clin Oncol; 1998 Aug; 16(8):2715-21. PubMed ID: 9704722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
    Vokes EE; Haraf DJ; Mick R; McEvilly JM; Weichselbaum RR
    J Clin Oncol; 1994 Nov; 12(11):2351-9. PubMed ID: 7525886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Wright JE; Norris CM; Busse PM; Lucarini JW; Fallon BG; Casey D; Andersen JW; Klein R
    Ann Intern Med; 1990 Feb; 112(3):167-72. PubMed ID: 2297193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
    Haraf DJ; Vokes EE; Weichselbaum RR; Panje WR
    Laryngoscope; 1992 Jun; 102(6):630-6. PubMed ID: 1602911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer.
    Alba E; Sanchez-Chaparro MA; Alonso L; Ribelles N; Ramon Delgado J; Rueda A; Pablo Tenllado P; Solano J; Urquiza R
    Am J Clin Oncol; 1996 Apr; 19(2):140-3. PubMed ID: 8610637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study.
    Fountzilas G; Tolis C; Kalogera-Fountzila A; Misailidou D; Tsekeris P; Karina M; Nikolaou A; Samantas E; Makatsoris T; Athanassiou E; Skarlos D; Bamias A; Zamboglou N; Economopoulos T; Karanastassi S; Pavlidis N; Daniilidis J
    Med Oncol; 2005; 22(3):269-79. PubMed ID: 16110138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.